Literature DB >> 14412744

Absorption of orally administered neomycin and kanamycin with special reference to patients with severe hepatic and renal disease.

C M KUNIN, T C CHALMERS, C M LEEVY, S C SEBASTYEN, C S LIEBER, M FINLAND.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/therapy; KIDNEY DISEASES/therapy; LIVER DISEASES/therapy; NEOMYCIN/therapy

Mesh:

Substances:

Year:  1960        PMID: 14412744     DOI: 10.1056/NEJM196002252620802

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

1.  ORAL NEOMYCIN: A POSSIBLE ANAESTHETIC HAZARD.

Authors:  E D ROSS; J A SETTLE; A B TELFER
Journal:  Br Med J       Date:  1963-11-02

2.  Kanamycin: a review and report of clinical experiences with Pr. vulgaris infections.

Authors:  K C RODGER; R W LEE; H O TONNING
Journal:  Can Med Assoc J       Date:  1961-09-23       Impact factor: 8.262

3.  Vancomycin in resistant hepatic encephalopathy.

Authors:  A Forbes; I Murray-Lyon
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

Review 4.  Antibacterial Drugs today: II.

Authors:  A P Ball; J A Gray; J M Murdoch
Journal:  Drugs       Date:  1975       Impact factor: 9.546

5.  Consequences of acute renal failure relevant to hepatic failure.

Authors:  M J Weston; S P Wilkinson
Journal:  Postgrad Med J       Date:  1975-08       Impact factor: 2.401

Review 6.  The treatment of hepatic encephalopathy.

Authors:  Marsha Y Morgan; A Blei; K Grüngreiff; R Jalan; G Kircheis; G Marchesini; O Riggio; Karin Weissenborn
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

7.  Suppression of the gut microbiome ameliorates age-related arterial dysfunction and oxidative stress in mice.

Authors:  Vienna E Brunt; Rachel A Gioscia-Ryan; James J Richey; Melanie C Zigler; Lauren M Cuevas; Antonio Gonzalez; Yoshiki Vázquez-Baeza; Micah L Battson; Andrew T Smithson; Andrew D Gilley; Gail Ackermann; Andrew P Neilson; Tiffany Weir; Kevin P Davy; Rob Knight; Douglas R Seals
Journal:  J Physiol       Date:  2019-02-27       Impact factor: 5.182

Review 8.  Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.

Authors:  K Mörike; M Schwab; U Klotz
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

9.  Oral neomycin dosage schedules for suppression of ammonia production by bowel flora.

Authors:  B Suh; J L Stephens; C M Kunin
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

10.  [Hepato-renal syndrome (author's transl)].

Authors:  J Kipnowski; R Düsing; H J Kramer
Journal:  Klin Wochenschr       Date:  1981-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.